| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Feb, 2026 | Feb, 2026 |
| Sales | 8,190 | 6,710 | 23,550 | 0 | 0 |
| Sales Growth | +22.06% | -71.51% | unch | unch | unch |
| Net Income | 2,370 | 2,250 | 10,010 | 0 | 0 |
| Net Income Growth | +5.33% | -77.52% | unch | unch | unch |
Anbio Biotechnology Cl A
(NNNN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Anbio Biotechnology is a diagnostic company dedicated to the advancement of medical technology and the provision of in vitro diagnostics products. Anbio Biotechnology is based in Frankfurt am Main, Germany.
Fiscal Year End Date: 12/31